Literature DB >> 15855209

ANCA-negative pauci-immune renal vasculitis: histology and outcome.

Ute Eisenberger1, Fadi Fakhouri, Philippe Vanhille, Hélène Beaufils, Alfred Mahr, Loic Guillevin, Philippe Lesavre, Laure-Hélène Noël.   

Abstract

BACKGROUND: Pauci-immune renal vasculitis with focal glomerular necrosis and crescent formation is usually associated with anti-neutrophil cytoplasmic antibodies (ANCAs). However, ANCA's are absent in up to 10% of cases, which constitutes a rarely studied variant of renal vasculitis.
METHODS: This retrospective multicentre cohort study analyzed the presenting features, renal histology and outcome in 20 patients with pauci-immune crescentic necrotizing renal vasculitis in whom indirect immunofluorescence did not detect ANCA.
RESULTS: Renal histology revealed a high percentage of active glomerular lesions (50%), mainly cellular crescents, 28% of them with glomerular necrosis. Chronic tissue damage with glomerulosclerosis (21%) and diffuse interstitial fibrosis (40%) was already present at diagnosis, more prominent than in historical PR3-positive patients. Infiltrates of polymorphonuclear neutrophils in glomerular capillary loops were observed in 40% of all biopsies, mainly in necrotic lesions. The subsets of interstitially infiltrating leukocytes similar to ANCA-associated disease. Microscopic polyangiitis was diagnosed in 17 patients, Wegener's granulomatosis in two and renal-limited vasculitis in one. The patients median disease extent index (DEI) of 5 (range 4-11) reflected a systemic vasculitis. ANCA-negative vasculitis was not associated with infection or malignancy. Renal outcome was correlated to DEI (P = 0.032) and serum creatinine at diagnosis (P = 0.04). The mortality rate was high (35%) and closely related to age above 65 years at diagnosis (P = 0.014). Conclusions. The histological findings and prognosis in ANCA-negative renal vasculitis are comparable with those of ANCA-positive disease. Our data underline the importance of the exact diagnosis in an active vasculitic disease process even in the absence of ANCAs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855209     DOI: 10.1093/ndt/gfh830

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  50 in total

1.  Diffuse tubulointerstitial nephritis associated with ANCA-negative pauci-immune glomerulonephritis.

Authors:  Go Kanzaki; Nobuo Tsuboi; Takashi Yokoo; Yoichi Miyazaki; Yasunori Utsunomiya; Tatsuo Hosoya
Journal:  Clin Exp Nephrol       Date:  2012-01-24       Impact factor: 2.801

2.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Authors:  Sanjeev Sethi; Mark Haas; Glen S Markowitz; Vivette D D'Agati; Helmut G Rennke; J Charles Jennette; Ingeborg M Bajema; Charles E Alpers; Anthony Chang; Lynn D Cornell; Fernando G Cosio; Agnes B Fogo; Richard J Glassock; Sundaram Hariharan; Neeraja Kambham; Donna J Lager; Nelson Leung; Michael Mengel; Karl A Nath; Ian S Roberts; Brad H Rovin; Surya V Seshan; Richard J H Smith; Patrick D Walker; Christopher G Winearls; Gerald B Appel; Mariam P Alexander; Daniel C Cattran; Carmen Avila Casado; H Terence Cook; An S De Vriese; Jai Radhakrishnan; Lorraine C Racusen; Pierre Ronco; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

Review 3.  EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

Authors:  Bernhard Hellmich; Oliver Flossmann; Wolfgang L Gross; Paul Bacon; Jan Willem Cohen-Tervaert; Loic Guillevin; David Jayne; Alfred Mahr; Peter A Merkel; Heiner Raspe; David G I Scott; James Witter; Hasan Yazici; Raashid A Luqmani
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

Review 4.  ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2009-04-28       Impact factor: 28.314

5.  Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.

Authors:  Duvuru Geetha; Caroline J Poulton; Yichun Hu; Philip Seo; Julie Anne G McGregor; Ronald J Falk; Susan L Hogan
Journal:  Semin Arthritis Rheum       Date:  2013-12-04       Impact factor: 5.532

Review 6.  Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives.

Authors:  Andrea Hinojosa-Azaola; Ariadna Jiménez-González
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

7.  Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN.

Authors:  Andrea Peschel; Neil Basu; Alexandra Benharkou; Ricarda Brandes; Markus Brown; Andrew J Rees; Renate Kain
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

8.  Pauci-immune crescentic glomerulonephritis associated with use of trimethoprim-sulfamethoxazole.

Authors:  Shruti S Hegde; Vanesa Bijol; Bertrand L Jaber
Journal:  CEN Case Rep       Date:  2016-06-07

9.  Health-related quality of life for patients with vasculitis and their spouses.

Authors:  Delesha M Carpenter; Carolyn T Thorpe; Megan Lewis; Robert F Devellis; Susan L Hogan
Journal:  Arthritis Rheum       Date:  2009-02-15

10.  ANCA negative pauci-immune glomerulonephritis with systemic involvement.

Authors:  K Sampathkumar; M Ramakrishnan; A K Sah; S Gowtham; R N Ajeshkumar
Journal:  Indian J Nephrol       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.